Abstract
The theme of this conference--excitotoxins (ET)--is a fascinating one that poses many intriguing research challenges and promises substantial rewards for the effort spent in pursuing these challenges. If we are right in suspecting that endogenous excitotoxins--glutamate (Glu), aspartate (Asp) and perhaps others--are the neurotransmitters released at the majority of excitatory synapses in the mammalian CNS, this is reason enough for our intrigue with these agents. If these transmitter candidates, which are distributed abundantly throughout the CNS, can attack and destroy central neurons, this suggests they might be involved in human neuropathological processes, a prospect that certainly enhances one’s level of interest. If by harnessing the powerful neurotoxic activities of ET, we can use them as tools to explore the magnificent organization and functions of the CNS, this is a splendid. bonus for which we must indeed be grateful. But there are many gaps in our understanding of these agents, gaps which can only be filled by years of methodical research, but gaps which must be filled if we are to decipher the roles of ET in the physiology and pathology of the CNS and realize their full potential as tools in neuroscience research. In this overview on ET lesions, I will not attempt a comprehensive review of the burgeoning literature on ET--a task that would be impossible within the time constraints--but rather will focus on a few key issues which I consider fundamental to our understanding of these agents and the lesions they induce.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ben-Ari Y, Tremblay E, Ottersen OP and Naquet R (1979). Brain Res 165, 632–635.
Biscoe TJ, Davies J, Dray A, Evans RH, Martin MR and Watkins JC (1977). Eur J Pharmac 45, 315–316.
Collins RC and Olney JW (1982). Science, in Press.
Colonnier M, Steriade M and Landry P (1979). Brain Res 172, 552–556.
Coyle JT and Schwarcz R (1976). Nature 263, 244–246.
Coyle JT, McGeer EG, McGeer PL and Schwarcz R (1978). In: Kainic Acid as a Tool in Neurobiology, McGeer EG, Olney JW, McGeer PL (Eds), Raven Press, New York.
Curtis DR and Watkins JC (1960). J Neurochem 6, 117–141.
DeMontigny C and Lund JP (1980. Neuroscience 5, 1621–1628.
Di Chiara G, Morelli M, Imperato A, Faa G, Fussarello M and Porceddu ML (1981). In: Glutamate as a Neurotransmitter, Di Chiara G and Gessa GL (Eds), Raven Press, New York.
Evans RH (1980). J Physiol 298, 25–35.
Evans RH, Francis AA, Hunt K, Oakes DJ and Watkins JC (1979). Br J Pharmacol 67, 591–603.
Fuller TA and Olney JW (1981). Neurobehav Toxicol Teratol 3, 355–361.
Fuller TA, Olney JW and Conboy VT (1981). Neurosci Abst 7, 811, 1981.
Hall JG, Hicks TP and McLennan H (1977). Neurosci Lett 8, 171–175.
Hattori T and McGeer EG (1977). Brain Res 129, 174–180.
Heggli DE, Aamodt A, Malthe-Sorenssen D (1981). Brain Res 230, 253–262.
Honchar MP, Olney JW and Sherman WR (1982). Neurosci Abst 8.
Hosli L, Andres P and Hosli E (1979). J Physiol (Paris) 75, 655–659.
Krespan B, Berl S and Nicklas WJ (1982). J Neurochem 38, 509–517.
Labruyere J, Olney JW and Collins RC (1982). Neurosci Abst 8.
London ED and Coyle JT (1979). Eur J Pharmacol 56, 287–290.
London ED, Klemm N and Coyle JT (1980). Brain Res 192, 463–476.
McLennan H (1981). In: Glutamate as a Neurotransmitter, Di Chiara G, Gessa GL (Eds), Raven Press, New York.
McLennan H and Hall JG (1978). Brain Res 149, 541–545.
Olney JW (1971). J Neuropathol Exp Neurol 30, 75–90.
Olney JW (1978). In: Kainic Acid as a Tool in Neurobiology, McGeer EG, Olney JW, McGeer PL (Eds), Raven Press, New York.
Olney JW (1979). In: Huntington’s Disease, Chase TN, Wexler NS, Barbeau A (Eds), Raven Press, New York.
Olney JW (1981). In: Glutamate as a Neurotransmitter, Di Chiara G, Gessa GL (Eds) Raven Press, New York.
Olney JW and deGubareff T (1978a). Brain Res 140, 340–343.
Olney JW and deGubareff T (1978b). In: Kainic Acid as a Tool in Neurobiology, McGeer EG, Olney JW, McGeer PL (Eds), Raven Press, New York.
Olney JW and Price MT (1980). Brain Res Bull 5, Suppl 2, 361–368.
Olney JW and Sloviter RS (1981). J Neuropath Exp Neurol 40, 340.
Olney JW, Ho OL and Rhee V (1971). Exp Brain Res 14, 61–76.
Olney JW, Sharpe LG and deGubareff T (1975). Neurosci Abst 1, 371.
Olney JW, deGubareff T and Labruyere J (1979a). Life Sci 25, 537–540.
Olney JW, Fuller T and deGubareff T (1979b). Brain Res 176, 91–100.
Olney JW, deGubareff T and Collins JF (1980a). Neurosci Lett 19, 277–282.
Olney JW, Fuller TA, Collins RC and deGubareff T (1980b). Brain Res 200, 231–235.
Olney JW, Fuller TA and deGubareff T (1981a). Nature 292, 165–167.
Olney JW, Fuller TA, deGubareff T and Labruyere J (1981b). Neurosci Lett 25, 185–191.
Olney JW, Labruyere J, Collins JF and Curry K (1981c). Brain Res 221, 207–210.
Olney JW, Collins JF and deGubareff T (1982a). Brain Res in press.
Olney JW, deGubareff T and Labruyere J (1982b). Neurosci Abst 8.
Plaitakis A, Berl S and Yahr MD (1982). Science 216, 193.
Price MT, Haft R and Olney JW (1981). Neurosci Abst 7, 714.
Price MT, Olney JW and Cicero TJ (1978). Neuroendocrinology 26, 352–358.
Rowlands GJ and Roberts PJ (1980). Europ J Pharmacol 62, 241.
Ruck A, Kramer 5, Metz J and Brennan MJW (1980). Nature 287, 852–853.
Schwarcz R, Scholz D and Coyle TJ (1978). Neuropharmacology 17, 145–151.
Schwarcz R, Hokfelt T, Fuxe K, Johnson G, Goldstein M, Terenius L (1979). Exp Brain Res 37, 199–216
Simon JR, Contrera JF and Kuhar MJ (1976). J Neurochem 26, 141–147.
Sloviter RS and Damiano BP (1981). Neurosci Lett 24, 279–284.
Stone TW and Perkins MN (1981). Eur J Pharmacol 72, 411–412.
Stone TW, Perkins MN, Collins JF and Curry K (1981). Neuroscience 6, 2249–2252.
Watkins JC (1978). In: Kainic Acid as a Tool in Neurobiology, McGeer EG, Olney JW, McGeer PL (Eds), Raven Press, New York.
Watkins JC, Davies J, Evans RH, Francis AA and Jones AW (1981). In: Glutamate as a Neurotransmitter, Di Chiara G, Gessa GL (Eds), Raven Press, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1983 The Wenner-Gren Center
About this chapter
Cite this chapter
Olney, J.W. (1983). Excitotoxins: An Overview. In: Fuxe, K., Roberts, P., Schwarcz, R. (eds) Excitotoxins. Wenner-Gren Center International Symposium Series. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06963-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-349-06963-7_7
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06965-1
Online ISBN: 978-1-349-06963-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)